Mission Video
Bring Your Health to Light!
Command Longevity
Because the earlier a problem is detected,
the clearer your path to health.


That’s why we’re working to provide visibility
into an individual’s Realtime state of health,
by delivering the most accurate early
cancer detection results possible before
symptoms occur.
WHAT WE DO
Advanced Proteomic Diagnostics,
Take the Miss Out of Diagnosis.
Game-changing blood testing for MPS-1,
27 Plus years in the making.
 

READ ABOUT MPS-1
Previous
Next
Bring Your Health to Light!
Command Longevity

Because the earlier a problem is detected,
the clearer your path to health.

That’s why we’re working to provide visibility
into an individual’s Realtime state of health,
by delivering the most accurate early
cancer detection results possible before
symptoms occur.
WHAT WE DO
Advanced Proteomic Diagnostics,
Take the Miss Out of Diagnosis.
Game-changing blood testing for MPS-1,
27 Plus years in the making.
 

READ ABOUT MPS-1
Previous
Next
We’re working to provide the diagnostics that enable early detection of all cancers,
to be as simple as a routine blood test during an annual checkup.
"
Detecting Cancer takes too long, so we found a way to detect problems early, before symptoms develop, when they can most effectively be cured.
... Paul Hamilton, Chief Science Officer.
“Detecting Cancer takes too long, so we found a way to detect problems early, before symptoms develop, when they can most effectively be cured.”
... Paul Hamilton, Chief Science Officer
When available, regular cancer screenings have been shown to reduce even prevent cancer mortality … so the earlier that cancer is detected, the better the chance of successful treatment.

Our Mission

Today Cancer remains the 2nd leading cause of death in the United States. Cancer diagnoses can be devastating, being often detected late, as current testing is inefficient, and limited to only a few specific cancers.

The National Cancer Screen is out to change the narrative by transforming healthcare with a game-changing, universal cancer screening, single draw blood test that shows promise to detect problems earlier when they are most treatable, reduce the cost of care, and empower better health and longevities.
WHAT WE DO

Our Approach

We are leveraging affordable, advanced proteomic diagnostic technologies
utilizing a single common marker MPS-1, to make reliable early-stage, blood-based universal cancer detection and monitoring, an accessible routine procedure in standard medical care.
MPS 1 TEST

Our Approach

We are leveraging affordable, advanced proteomic diagnostic technologies
utilizing a single common marker MPS-1, to make reliable early-stage, blood-based universal cancer detection and monitoring, an accessible routine procedure in standard medical care.
MPS 1 TEST

Partner Patient Support

To educate and raise awareness of mps-1 and its potential as a candidate for universal cancer detection,
we are working to assemble clinical partner and patient support resources, as well as establish further clinical data and testing to enhance MPS-1 diagnostic capabilities.
Support

Who We Are

The National Cancer Screen is a post development research lab, focused on exploiting and delivering advanced proteomic diagnostics for early cancer detection and monitoring.
WHO WE ARE

Who We Are

The National Cancer Screen is a post development research lab, focused on exploiting and delivering advanced proteomic diagnostics for early cancer detection and monitoring.
WHO WE ARE
HELP

MAKE YOUR MARK

*From Venture Partners to Clinical or Research Implementations or Media.  

Get on Board

© 2021 National Cancer Screen, LLC.  All rights reserved. 

  • © 2021 National Cancer Screen, LLC.
    All rights reserved.